14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 8 May 2024

Trading levels for AMPE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.262 16.30 %
R2 0.250 11.20 %
R1 0.243 8.06 %
Current price: 0.225
Support S1 0.220 -2.13 %
S2 0.213 -5.28 %
S3 0.202 -10.37 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.251 11.56 %
R2 0.250 11.11 %
R1 0.242 7.56 %
Current price 0.225
Support S1 0 .
S2 0 .
S3 0 .

AMPE Predictions History

3 years ago
hfekry.stmaryde.221132 predicted that AMPE for 2021-03-08 is going

Rank:

3 years ago
JS predicted that AMPE for 2021-02-22 is going $2.00 (9.29%)

3 years ago
Teej predicted that AMPE for 2021-02-22 is going

Rank:

3 years ago
JS predicted that AMPE for 2020-12-22 is going $2.14 (-22.46%)

3 years ago
JS predicted that AMPE for 2020-12-21 is going $2.28 (-0.87%)

3 years ago
Jon.Hutton.104268 predicted that AMPE for 2020-12-21 is going

Rank:

3 years ago
MahmoudHamad predicted that AMPE for 2020-12-21 is going

Rank:

3 years ago
JS predicted that AMPE for 2020-12-18 is going $1.83 (-24.07%)

3 years ago
JS predicted that AMPE for 2020-12-08 is going $1.15 (-14.81%)

3 years ago
JS predicted that AMPE for 2020-12-03 is going $0.99 (-8.06%)

Click to get the best stock tips daily for free!

About Ampio Pharmaceuticals Inc

Ampio Pharmaceuticals Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requi... AMPE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT